Life Sciences Mergers and Acquisitions is an authoritative, insider's perspective on best practices for advising life sciences companies engaging in mergers and acquisitions. Featuring partners and chairs from some of the nation's leading law firms, these experts guide the reader through each stage of the transaction and the key considerations for each stage, offering advice for attorneys and management teams on how to prepare for and facilitate the deal. These top lawyers reveal their advice on key regulatory and intellectual property due diligence items, including assessing the target's regulatory undertakings and identifying and establishing the status of relevant IP assets. From outlining management objectives to assessing risk, these authors explain the importance of understanding the nature of the client's business when structuring the specific terms of the deal. Additionally, these leaders give tips on how to avoid common mistakes, work with key players, and address potential antitrust issues. The different niches represented and the breadth of perspectives presented enable readers to get inside some of the great legal minds of today, as these experienced lawyers offer up their thoughts around the keys to navigating this complex and rapidly-changing area of law.

Inside the Minds provides readers with proven business intelligence from C-Level executives (Chairman, CEO, CFO, CMO, Partner) from the world's most respected companies nationwide, rather than third-party accounts from unknown authors and analysts. Each chapter is comparable to an essay/thought leadership piece and is a future-oriented look at where an industry, profession, or topic is headed and the most important issues for the future. Through an exhaustive selection process, each author was hand-picked by the Inside the Minds editorial board to author a chapter for this book.

Chapters Include:

1. Jeremiah T. Mulligan, Partner, Curtis, Mallet-Prevost, Colt & Mosle "Preparation, Organization, and Communication: Accomplishing Profitable Mergers and Acquisitions in the Life Sciences Arena"

2. Stephen Paul Mahinka, Partner and Chair, Life Sciences Interdisciplinary Practice, Morgan Lewis "The Centrality of Regulatory Due Diligence in Life Sciences M&A"

3. Stephen Albainy-Jenei, Member, Frost Brown Todd LLC "Adding Value to Intellectual Property Portfolios"

4. Eric Klein, Partner, Sheppard Mullin Richter & Hampton LLP "Building Your Deal Documents for a Successful Transaction: Practice Points and Pressure Points"

5. Peter T. Healy, Partner, O Melveny & Myers LLP "Successful Strategies and Key Considerations in Life Sciences M&A"

6. Eileen Smith Ewing, Partner, Kirkpatrick & Lockhart Preston Gates & Ellis LLP "Different Stakeholders, Different Deal Goals: Counseling the Merger or Sale of a Life Sciences Company"